Moreover, the overexpression of Ezrin often correlates with poor prognosis of patients in cervical cancer, osteosarcoma, colorectal adenocarcinoma, and gastrointestinal cancers [2, 3]. The gene discussed is EZR; the disease is osteosarcoma.